Implantable Infusion Pump Market is Anticipated to Surge at a Moderate CAGR of 4.5% by 2026, Estimates DelveInsight

An increasing prevalence of various disorders such as diabetes, cancer, chronic pain, and various other disorders, the rising geriatric population and, integration of advanced technology are some of the key factors, which are expected to increase the overall demand for Implantable Infusion Pump, thus driving the growth of Implantable Infusion Pump market.

LAS VEGAS, Nov. 16, 2021 /PRNewswire/ -- DelveInsight's Implantable Infusion Pump Market Insights and Forecast report provides the current and forecast Implantable Infusion Pump Market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Implantable Infusion Pump Market. 

Some of the salient features from the Implantable Infusion Pump Market report: 

• As per an analysis by DelveInsight, North America is expected to dominate the overall Implantable Infusion Pump Market during the forecast period.
• Major pharma players working proactively in the Implantable Infusion Pump Market include Medtronic, Intera Oncology, FLOWONIX MEDICAL INC, Tandem Diabetes Care, Inc., and others.
• DelveInsight analysis indicates that the Implantable Infusion Pump market is expected to grow at a CAGR of 4.5% during the forecast period from 2021 to 2026.
• In February 2019, the US Food and Drug Administration permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes, owing to the launch of such devices, there will be a rapid growth observed in the Implantable Infusion Pumps market during the forecast period.

Track the latest highlights related to Autoinjectors, get the snapshot of the key highlights entailed in the Implantable Infusion Pump Market report.

Implantable Infusion Pump Market Overview 

Implantable Infusion Pumps are small devices placed underneath the skin during surgery, which sends liquid pain medicine using a thin, flexible tube known as a catheter to a specific part of the body and offer targeted and consistent medicine to reduce pain. These pumps can be used in various medical applications such as in the management of chronic pain, oncology, diabetes, and other procedures. Pain is caused due to an unpleasant sensory stimulation that occurs because of tissue damage by any means, mainly constituting injuries and diseases such as arthritis, cancer, ulcers among others. These are mainly divided into two groups, nociceptive pain and neuropathic pain. Many drugs such as analgesics and painkillers as well as several devices like Neuromodulation & Neurostimulation Devices, Ablation Devices, and Analgesic Infusion Pumps are available to help relieve the pain.

Interested in knowing how the Implantable Infusion Pump Market will be growing by 2026? Click to get a snapshot of Implantable Infusion Pump Market Analysis

Implantable Infusion Pump Market Insight 

Geographically, the global Implantable Infusion Pump market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. Whereas if the revenue share is concerned then North America is currently considered the leader in the global Implantable Infusion Pump market and also is expected to remain constant during the forecast period. This domination is observed majorly owing to the growing cases of chronic disorders, rising healthcare expenditure due to a strong economy, and the presence of well-established healthcare infrastructure.

Several recent developments, such as product launches, are also driving the market growth; for instance, in February 2020, FDA approval was granted to Flowonix in order to market Prometra® II Pump for use with Intrathecal Baclofen.

To know more about why North America is leading the market growth in the Implantable Infusion Pump market, get a snapshot of the report Implantable Infusion Pump Market

Implantable Infusion Pump Market Dynamics

The rising prevalence of chronic pain is expected to fuel the market for Implantable Infusion Pumps as chronic pain patients and new cancer cases will require continuous drug delivery for better management. The rising healthcare costs, improving healthcare infrastructure population and growing healthcare expenditure are projected to augment the Implantable Infusion Pump market.

The demand for an Implantable Infusion Pump is moderately affected by the outburst of the COVID-19 pandemic due to the delay in elective surgeries required for the implantation of an Implantable Infusion Pump. As a result, stopping or delaying the treatment for chronic pain patients will have negative consequences, and strong pain evaluations must be administered to triage patients appropriately.

To get a deeper understanding of the driving factors related to the Implantable Infusion Pump Market, get a snapshot of the Implantable Infusion Pump Market Outlook

Scope of the Implantable Infusion Pump Market Report

Study Period: 2018-2026

Key Companies: Medtronic; Intera Oncology, FLOWONIX MEDICAL INC, Tandem Diabetes Care, Inc.

Implantable Infusion Pump Market Segmentation

By Application

• Chronic Pain
• Diabetes
• Oncology
• Others

By End-User

• Hospitals
• Ambulatory Surgical Centres
• Homecare Settings
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Rest of World

Delveinsight Analysis: The Implantable Infusion Pump Market is expected to grow at a CAGR of 4.5%

during the forecast period from 2021 to 2026.

Table of Contents 

Learn more about the Implantable Infusion Pump Market Landscape @ Implantable Infusion Pump Market Landscape

Understand the Competition, Risk Assessment and effective Research and Development approach to take value-based decisions.

Related Reports

Diabetes Pen Market

DelveInsight's 'Diabetes Pen- Market Insights, Competitive Landscape and Market Forecast - 2026' report delivers an in-depth understanding of Diabetes Pen and the historical and forecasted Diabetes Pen market trends,market drivers, market barriers and key companies involved such as AstraZeneca, Teruma Medical Corporation, Greinier Bio One International GmBH, F. Hoffman La Roche AG, Becton, Dickinson and Company Bayer Cropscience Ltd, HTL STREFA SA, and others.

Chronic Pain associated with Painful Diabetic Neuropathy Market

DelveInsight's 'Chronic Pain associated with Painful Diabetic Neuropathy- Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Chronic Pain associated with Painful Diabetic Neuropathy covering the market trends, market drivers, market barriers and key companies involved such as Janssen Pharmaceuticals, Grunethal, Pfizer, Eli Lilly, Shionogi, Ono pharmaceuticals, Fremslife S.r.l,  Helixmith, Aptinyx, Regenacy Pharmaceuticals, Novaremed, Nevro Corp, Erchonia Corporation, and others.

Injectable Drug Delivery Devices Market 

Global Injectable Drug Delivery Devices Market was valued at USD 17.65 billion in 2020, growing at a CAGR of 11.25% during the forecast period from 2021 to 2026, to reach USD 33.37 billion by 2026. The report delivers an in-depth understanding of Injectable Drug Delivery Devices and the historical and forecasted market trends, market drivers, market barriers and key companies involved such as Eli Lilly and Company, Biocon, Becton, Dickinson & Company, West Pharmaceutical Services, Johnson & Johnson, Antares Pharma, AbbVie Inc, Pfizer Inc, Mylan N.V. and others.

Catheter-Related Bloodstream Infection Market

DelveInsight's 'Catheter-Related Bloodstream Infection (CRBSI) -Market Insights, Epidemiology, and Market Forecast-2030' report deliver an in-depth understanding of the catheter-related bloodstream infection, historical and forecasted epidemiology as well as key companies involved in pipelines such as CorMedix, Geistlich Pharma, TauroPharm GmbH, Fresenius Medical Care, and others.

Smart Insulin Pens Market 

DelveInsight's 'Smart Insulin Pens Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of Smart Insulin Pens and the historical and forecasted Smart Insulin Pens market trends, market drivers, market barriers and key companies involved such as Novo Nordisk, DiabNext, InsulCloud, Medtronic, Companion Medical, Biocorp, Bigfoot Medical, Emperra GmbH E-Health Technologies, and others.

Browse Through Our Blog Posts

• Evolution in Diabetes Management
• Medical Devices Market Blooms as the Key MedTech Companies Continue to Bring-In Innovation
• Cost-effectiveness, Advanced Technology, Rising Demand Pushes the Insulin Delivery Devices Market

Connect With Us at LinkedIn | Facebook | Twitter

Contact Us
Shruti Thakur 
info@delveinsight.com 
+1(919)321-6187 
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

SOURCE DelveInsight Business Research, LLP